145 related articles for article (PubMed ID: 38219807)
1. Mechanisms of hepatocellular toxicity associated with the components of St. John's Wort extract hypericin and hyperforin in HepG2 and HepaRG cells.
Abegg VF; Panajatovic MV; Mancuso RV; Allard JA; Duthaler U; Odermatt A; Krähenbühl S; Bouitbir J
Toxicol Lett; 2024 Mar; 393():1-13. PubMed ID: 38219807
[TBL] [Abstract][Full Text] [Related]
2. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
Hostanska K; Reichling J; Bommer S; Weber M; Saller R
Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
[TBL] [Abstract][Full Text] [Related]
3. Comparison of German St. John's wort products according to hyperforin and total hypericin content.
Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilavecz M
J Am Pharm Assoc (Wash); 2001; 41(4):560-6. PubMed ID: 11486982
[TBL] [Abstract][Full Text] [Related]
4. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
[TBL] [Abstract][Full Text] [Related]
5. Current St John's wort research from mode of action to clinical efficacy.
Müller WE
Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
[TBL] [Abstract][Full Text] [Related]
6. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
Barnes J; Anderson LA; Phillipson JD
J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
[TBL] [Abstract][Full Text] [Related]
7. [St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology].
Schempp CM; Müller KA; Winghofer B; Schöpf E; Simon JC
Hautarzt; 2002 May; 53(5):316-21. PubMed ID: 12063742
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of St John's wort in depression : what is known?
Butterweck V
CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
[TBL] [Abstract][Full Text] [Related]
9. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
Ng QX; Venkatanarayanan N; Ho CY
J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
[TBL] [Abstract][Full Text] [Related]
10. St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1.
Schwarz D; Kisselev P; Roots I
Cancer Res; 2003 Nov; 63(22):8062-8. PubMed ID: 14633740
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the synaptosomal uptake inhibition of serotonin by St John's wort products.
Schulte-Löbbert S; Holoubek G; Müller WE; Schubert-Zsilavecz M; Wurglics M
J Pharm Pharmacol; 2004 Jun; 56(6):813-8. PubMed ID: 15231048
[TBL] [Abstract][Full Text] [Related]
12. St. John's wort.
Lawvere S; Mahoney MC
Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
[TBL] [Abstract][Full Text] [Related]
13. St. John's wort does not interfere with therapeutic drug monitoring of 12 commonly monitored drugs using immunoassays.
Dasgupta A; Tso G; Szelei-Stevens K
J Clin Lab Anal; 2006; 20(2):62-7. PubMed ID: 16538644
[TBL] [Abstract][Full Text] [Related]
14. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
Wang EJ; Barecki-Roach M; Johnson WW
J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
[TBL] [Abstract][Full Text] [Related]
15. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
[TBL] [Abstract][Full Text] [Related]
16. Determination of total hypericins in St. John's wort and herbal medicinal products.
Anyzewska M; Kowalczuk A; Łozak A; Jabłczyńska R; Fijałek Z
Acta Pol Pharm; 2010; 67(6):586-92. PubMed ID: 21229872
[TBL] [Abstract][Full Text] [Related]
17. [Mania during the use of a combination preparation with St. John's wort (Hypericum perforatum)].
Güzelcan Y; Scholte WF; Assies J; Becker HE
Ned Tijdschr Geneeskd; 2001 Oct; 145(40):1943-5. PubMed ID: 11675976
[TBL] [Abstract][Full Text] [Related]
18. St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?
Kholghi G; Arjmandi-Rad S; Zarrindast MR; Vaseghi S
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jun; 395(6):629-642. PubMed ID: 35294606
[TBL] [Abstract][Full Text] [Related]
19. About the cover: St. John's wort.
J Soc Integr Oncol; 2006; 4(1):52-5. PubMed ID: 16737673
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
